It’s one of the biggest pseudo science cons in history – the idea currently being promoted by government officials and the media that natural immunity cannot protect you against the greatest viral pathogen in human history, the ‘novel’ coronavirus.
Last month, the Food and Drug Administration (FDA) in Washington issued a statement saying that SARS-CoV-2 antibody tests should not be used to determine immunity or protection against COVID-19. The agency did not clarify why they suddenly decreed this latest ‘science’ decision. It was just left there, vague and with the sort of aloof, self-referential authority that the public has become accustomed to over the last 16 months during this so-called ‘global pandemic.’
The only logical answer here is that the US government, in collusion with the transnational corporate vaccine cartel, are attempting to herd the population into a carefully designed cul de sac governed by a fraudulent PCR testing trap, whilst simultaneously coercing the population to accept the unlicensed experimental genetic ‘vaccine’ injections. Why? Upon closer examination, it appears that the antigen (antibody) test puts more power back into the hands of the individual, and away from the oppressive government ‘public health’ machine and its pharmaceutical industrial complex.
In this sense, any acknowledgement of natural immunity of a human is met with distain and ridicule by the pandemic pushers.
Moreover, a positive antibody test for SARS-CoV-2 would also logically mean that the state or a corporation could not compel or force an individual to inject any of these potentially dangerous experimental ‘vaccines’ being pushed aggressively by governments and their many ‘stakeholders.’
This is a very cynical and shrewd move by the FDA, but it’s very much in keeping with every other illogical move they’ve made over the past 15 months.
write in Medpage Today…
Epidemiologists estimate over 160 million people worldwide have recovered from COVID-19. Those who have recovered have an astonishingly low frequency of repeat infection, disease, or death. That immunity from prior infection protects many people now where vaccines are not yet available.
Earlier this month the World Health Organization released a scientific update stating that most people who have recovered from COVID-19 develop a strong protective immune response. Importantly, they summarize that within 4 weeks of infection, 90% to 99% of people who recover from COVID-19 develop detectable neutralizing antibodies. Furthermore, they conclude — given the limited amount of time to observe cases — that the immune response remains strong for at least 6 to 8 months after infection.
This update echoes what the NIH reported in January 2021: The immune response of more than 95% of people who recovered from COVID-19 had durable memories of the virus up to 8 months after infection. The NIH went further to state that those findings “provide hope” that people who get vaccinated will develop similar lasting immunity.
So why are we so focused on vaccine-induced immunity — in our goals to reach herd immunity, our gatekeeping on travel, public or private events, or mask use — while ignoring natural immunity? Shouldn’t those who have natural immunity also be able to return to “normal” activities?
Numerous scientists have found that there is a decreased risk of re-infection and extremely low rates of hospitalization and death due to repeat infection. The range of reduction of re-infection from COVID-19 was between 82% to 95% among six studies that encompassed nearly 1 million people conducted in the U.S., the U.K., Denmark, Austria, Qatar, and among U.S. Marines. The study in Austria also found that the frequency of re-infection from COVID-19 caused hospitalization in only five out of 14,840 (0.03%) people and death in one out of 14,840 (0.01%).
In addition, newer U.S. data, released after the January NIH announcement, found protective antibodies lasting up to 10 months following infection.
As public health policymakers reduce the discussion of immunity to vaccination status, largely ignored are the complexities of the human immune system. There are multiple highly encouraging research reports showing that blood cells in our body, so called “B cells and T cells,” contribute to the cellular immunity after COVID-19. If SARS-CoV-2 immunity is similar to other severe coronavirus infections like SARS-CoV-1 immunity, that protection could last at least 17 years. However, tests to measure cellular immunity are complex and expensive, making them hard to get and preventing their use in routine medical practice or in public health surveys of the population.
The FDA has authorized numerous antibody tests. As with any test, they require financial costs and time to obtain results, and there are important differences in the performance of each test in terms of what the positive antibodies actually represent. A critical distinction is that some tests only detect antibodies found after natural infection, “N” antibodies, and some cannot differentiate between natural or vaccine-induced antibodies, “S” antibodies. Doctors and patients should beware of this and ask which antibodies the tests actually measure.
Last week, on May 19, the FDA issued a public safety communication stating that while SARS-CoV-2 antibody tests play an important role in identifying people who have been exposed to the SARS-CoV-2 virus and may have developed an adaptive immune response, antibody tests should not be used to determine immunity or protection against COVID-19. Huh?
While it is important to note that message, it is confusing. The FDA presented no data in their warning and left those alerted uncertain about why antibody testing should not be used to determine immunity or protection against COVID-19. The FDA statement went on to say that antibody tests should be used by those experienced with antibody testing. Not helpful…
Continue this story at Medpage Today
READ MORE VACCINE NEWS AT: 21st Century Wire Vaccine Files
PLEASE HELP SUPPORT OUR INDEPENDENT MEDIA PLATFORM HERE
